PT - JOURNAL ARTICLE ED - , TI - No benefit from mirtazapine for treating agitation in dementia AID - 10.1136/dtb.2022.000013 DP - 2022 May 01 TA - Drug and Therapeutics Bulletin PG - 68--68 VI - 60 IP - 5 4099 - http://dtb.bmj.com/content/60/5/68.short 4100 - http://dtb.bmj.com/content/60/5/68.full SO - Drug Ther Bull2022 May 01; 60 AB - Review of: Banerjee S, High J, Stirling S, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet 2021;398:1487–97.